March 10, 2025 | CME, HOPA2025, HemOnc, OncologyEducation, VolunteerAward

Medscape is proud to highlight Michelle A. Worst, PharmD, BCOP, MBA, CHCP, Senior Director and Team Lead of Clinical Strategy in Hematology/Oncology, for her well-deserved recognition as the recipient of the 2025 HOPA Volunteer Award. Michelle is being honored for her exceptional dedication through committee and task force contributions, as well as representing the Hematology/Oncology Pharmacy Association (HOPA) at external events. Her commitment to hematology/oncology and her efforts in advancing education and collaboration make her a true leader in the field.
Reflecting on this recognition, Michelle shared, “My work in hematology/oncology is deeply personal, and I am passionate about advancing education, fostering collaboration, and ensuring we continue to elevate the standard of care for patients. Through my involvement in HOPA—whether shaping conference content, mentoring colleagues, or strategizing for the organization’s future—I’ve been fortunate to work alongside inspiring professionals who share a common goal: making a meaningful impact in oncology. I look forward to continuing this journey, driving innovation, and supporting the next generation of leaders in our field.”
Michelle will be formally honored at the 2025 HOPA Annual Conference during the Annual Member Business Meeting on Thursday, April 10th, at 10:50 AM PST.
At Medscape, we are committed to being the thread that runs through healthcare, connecting professionals with trusted education and insights that drive meaningful change. Our collective voice is one of credibility, passion, and an unwavering dedication to oncology education. Michelle’s contributions exemplify the spirit of volunteerism that strengthens the oncology community, and we celebrate her dedication to improving patient care. As we honor her remarkable achievements, we also look forward to our continued engagement at HOPA 2025.
Medscape will extend its presence at the HOPA Conference with our symposium:
Join us as we celebrate Michelle’s accomplishments and continue to advance oncology education together. Congratulations, Michelle, on this well-earned recognition!
For more information on Hematology/ Oncology Education please contact: Jelena Spyropoulos
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education had one of its biggest conferences of the year with IDWeek 2023, hosting six educational symposia and presenting five scientific posters highlighting the outcomes of recent infectious disease...
On the 8th November 2023, Medscape will launch the first episode of their new podcast: the Women in Healthcare Leadership Podcast Series.This insightful series was designed to elevate and empower...
Medscape Education has launched their new podcast: the Women in Healthcare Leadership Podcast Series. The series, hosted by Medscape Education employees, features women in leadership roles across industry as well...
During ECTRIMS 2023 congress, the Medscape Education Global team will be on site to present a poster of their educational outcomes.The poster, Virtual Patient Simulation Improves Neurologists’ Performance in Making...
The Medscape Oncology team will be on the road again, this time in Madrid, Spain for ESMO 2023. This year, the team will be sharing education with a deep impact...
The Medscape Education Global team is looking forward to a busy time in Berlin at the EADV Congress 2023. During the congress, Medscape will be presenting five posters examining the...
Medscape are powering education and disease state awareness in infectious diseases at #IDWeek 2023
As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...
From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...
Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...
